Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
64.8 USD | -2.17% | +0.89% | +14.16% |
Apr. 29 | North American Morning Briefing : Investors Brace -2- | DJ |
Apr. 26 | Stifel Upgrades LeMaitre Vascular to Buy From Hold, Adjusts Price Target to $75 From $59 | MT |
Evolution of the average Target Price on LeMaitre Vascular, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering LeMaitre Vascular, Inc.
Stifel Nicolaus | |
Barrington Research | |
JMP Securities | |
Oppenheimer | |
Jefferies & Co. | |
Roth MKM | |
Roth Capital Partners | |
KeyBanc Capital Markets |
EPS Revisions
- Stock Market
- Equities
- LMAT Stock
- Consensus LeMaitre Vascular, Inc.